Name | Nefazodone HCL |
Synonyms | NEFAZODONE Nefazodone HCL Nefazodone HCl NEFAZODONE-D5 HCL Nefazodone hydrochloride Nefazodone Hydrochloride Nefazodone Hydrochloride (200 mg) 2,4-Dihydro-2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride 3H-1,2,4-Triazol-3-one, 2-3-4-(3-chlorophenyl)-1-piperazinylpropyl-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride BMY-13754, MJ-13754-1, Serzone, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl- 2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride |
CAS | 82752-99-6 |
InChI | InChI=1/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H |
Molecular Formula | C25H33Cl2N5O2 |
Molar Mass | 506.47 |
Melting Point | 186-188°C |
Boling Point | 599.6°C at 760 mmHg |
Flash Point | 316.4°C |
Solubility | DMSO: ~11mg/mL at60°C |
Vapor Presure | 2.46E-14mmHg at 25°C |
Appearance | solid |
Color | white |
Maximum wavelength(λmax) | 248nm(MeOH)(lit.) |
Merck | 14,6438 |
Storage Condition | Inert atmosphere,Room Temperature |
In vitro study | Nefazodone hydrochloride (BMY-13754) is a phenylpiperazine antidepressant with a mechanism of action that is distinct from those of other currently available drugs. Nefazodone hydrochloride potently and selectively blocks postsynaptic serotonin (5-hydroxytryptamine; 5-HT) 5-HT2A receptors and moderately inhibits serotonin and noradrenaline (norepinephrine) reuptake. Nefazodone hydrochloride is also an inhibitor of the hepatic P-450 isoenzyme CYP3A4. |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
UN IDs | UN1230 - class 3 - PG 2 - Methanol, solution |
WGK Germany | 3 |
RTECS | XZ5483009 |
HS Code | 2933595960 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.974 ml | 9.872 ml | 19.745 ml |
5 mM | 0.395 ml | 1.974 ml | 3.949 ml |
10 mM | 0.197 ml | 0.987 ml | 1.974 ml |
5 mM | 0.039 ml | 0.197 ml | 0.395 ml |